Systemic lupus erythematosus (SLE) is an autoimmune disease affecting multiple organ systems, and is characterized by the deposition of immune complexes and a large array of autoantibodies. Thrombosis is a relatively frequent and serious complication of SLE; however, renal infarction in young patients with antiphospholipid antibody-negative lupus has rarely been reported, and no pediatric case has been reported in Korea. A 12-year-old female patient was presented to our hospital with a 3-day history of nausea, vomiting, and right flank pain. She was diagnosed with SLE and lupus nephritis two years ago and was treated with corticosteroids and hydroxychloroquine, azathioprine. Abdominal computed tomography (CT) showed renal infarction in the upper pole of the right kidney. Subcutaneous low molecular weight heparin was started, and warfarin was also started simultaneously and continued for 3 months. After 3 months, only minimal atrophic changes were seen on the abdominal CT. She is doing well by maintaining oral anticoagulant therapy and is being followed up regularly through outpatient clinic visits.
Introduction
Renal infarction results from interruption of the normal blood supply to part of, or to the whole kidney. The major causes of renal infarction include emboli secondary to underlying cardiac problems, such as atrial fibrillation. According to Bourgault M et al, other causes of renal infarction include thrombi from suprarenal aorta atheroma, endocarditis, renal artery injury, spontaneous renal artery dissection, fibromuscular dysplasia, Ehlers-Danlos syndrome, hypercoagulable state including hereditary thrombophilia, hyperhomocysteinemia, antiphospholipid syndrome, nephrotic syndrome and idiopathic (1) . Thrombosis has been reported in approximately 10 to 26 percent of SLE patients and antiphospholipid antibodies (aPL) are important risk factors for thrombosis. Although SLE patients who test positive for antiphospholipid antibodies have a high incidence of thrombotic complications, not all patients with thrombotic events have aPL (2) . Other risk factors, such as inflammation, smoking, dyslipidemia can also contribute to thrombosis (3, 4) .
Although thombosis is a relatively frequent and serious complication of SLE, renal infarction in antiphospholipid antibody-negative lupus patient has rarely been reported in young patients, and no pediatric case has been reported in Korea.
Here, we report a case of an aPL-negative pediatric SLE patient suffering from renal infarction.
Case Report
A 12-year-old female patient presented to the hospital with a 3-day history of right flank pain, nausea, and vomiting. She was admitted to our pediatrics department two years ago, due to intermittent low-grade fever, rash over the nose, and arthralgia in the left elbow. At that time, the laboratory study results were as follows: serum antinuclear antibody (ANA), 1 : 640 (normal ＜1 : 40); anti-RNP antibody, 1,435 U/mL (by ELISA, normal ＜5 U/mL); anti-SM antibody, 344 U/mL (normal ＜5 U/mL); serum anti-double stranded DNA (dsDNA) antibody, 486.7 IU/mL (by ELISA, normal ＜5 IU/mL); anti-cardiolipin antibody IgG, equivocal; anti-cardiolipin antibody IgM, negative. Urinalysis showed 1 g of protein in 24 hrs and many RBC sediments. She underwent renal biopsy, and the histologic diagnosis was lupus nephritis, membranous type. Due to lupus nephritis, cyclophosphamide and glucocorticoid pulse therapy was started, and she was managed with monthly cyclophosphamide therapy for 6 months.
After the disease activity improved, she was followed up in the outpatient clinic with deflazacort 18 mg, hydroxychloroquine 200 mg, azathioprine 50 mg.
On admission, her blood pressure was 120/80 mmHg, heart rate was 90 beats/min, and body temperature was 37. 
Summary
Renal infarction should be suspected in cases of sudden unexplained flank or upper abdominal pain, even if the patient tests negative for the antiphospholipid antibody. Furthermore, the risk factors for thrombosis should be evaluated and managed in every patient with SLE.
